Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Ezeprogind

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Ezeprogind, Azp-2006 free base, Tr9yq07eln, 615539-20-3, Asp2006 free base, Unii-tr9yq07eln
    Molecular Formula
    C25H44N6
    Molecular Weight
    428.7  g/mol
    InChI Key
    KLKKWCPJBTXWOV-UHFFFAOYSA-N
    FDA UNII
    TR9YQ07ELN
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1H-benzimidazol-2-amine
    2.1.2 InChI
    InChI=1S/C25H44N6/c1-21(2)19-31(20-22(3)4)14-8-13-30-17-15-29(16-18-30)12-7-11-26-25-27-23-9-5-6-10-24(23)28-25/h5-6,9-10,21-22H,7-8,11-20H2,1-4H3,(H2,26,27,28)
    2.1.3 InChI Key
    KLKKWCPJBTXWOV-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)CN(CCCN1CCN(CC1)CCCNC2=NC3=CC=CC=C3N2)CC(C)C
    2.2 Other Identifiers
    2.2.1 UNII
    TR9YQ07ELN
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Ezeprogind

    2. Azp-2006 Free Base

    3. Tr9yq07eln

    4. 615539-20-3

    5. Asp2006 Free Base

    6. Unii-tr9yq07eln

    7. Chembl419432

    8. 615539-20-3 (free Base)

    9. N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1h-benzimidazol-2-amine

    10. N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine

    11. Ezeprogind [inn]

    12. Azp2006 Free Base

    13. Schembl2444189

    14. Klkkwcpjbtxwov-uhfffaoysa-n

    15. Bdbm50134471

    16. Akos040758235

    17. Hy-109172

    18. (1h-benzoimidazol-2-yl)-{3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-amine

    19. {3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-(1h-benzimidazol-2-yl)-amine

    20. 1,4-piperazinedipropanamine, N'-1h-benzimidazol-2-yl-n,n-bis(2-methylpropyl)-

    21. 1,4-piperazinedipropanamine, N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-

    22. N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-1,4-piperazinedipropanamine

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 428.7 g/mol
    Molecular Formula C25H44N6
    XLogP35.1
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count13
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area50.4
    Heavy Atom Count31
    Formal Charge0
    Complexity467
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of progressive supranuclear palsy